Further comments on "A practical prognostic index for inoperable non-small-cell lung cancer": a clinical biologist's point of view.
作者信息
Watine J
出版信息
J Cancer Res Clin Oncol. 1998;124(10):581-3. doi: 10.1007/s004320050218.
Abstract
摘要
相似文献
1
Further comments on "A practical prognostic index for inoperable non-small-cell lung cancer": a clinical biologist's point of view.关于《不可切除非小细胞肺癌的实用预后指数》的进一步评论：临床生物学家的观点
J Cancer Res Clin Oncol. 1998;124(10):581-3. doi: 10.1007/s004320050218.
2
Concurrent low-dose cisplatin and thoracic radiotherapy in patients with inoperable stage III non-small cell lung cancer: a phase II trial with special reference to the hemoglobin level as prognostic parameter.不可切除的 III 期非小细胞肺癌患者同步低剂量顺铂与胸部放疗：一项特别参照血红蛋白水平作为预后参数的 II 期试验
J Cancer Res Clin Oncol. 2005 Apr;131(4):261-9. doi: 10.1007/s00432-004-0633-0. Epub 2004 Dec 23.
3
The prognostic and clinicopathological value of HALP score in non-small cell lung cancer.HALP评分在非小细胞肺癌中的预后及临床病理价值
Front Immunol. 2025 Jun 26;16:1576326. doi: 10.3389/fimmu.2025.1576326. eCollection 2025.
4
A practical prognostic index for inoperable non-small-cell lung cancer.一种用于不可切除非小细胞肺癌的实用预后指数。
J Cancer Res Clin Oncol. 1997;123(5):259-66. doi: 10.1007/BF01208636.
5
Circulating U2 small nuclear RNA fragments as a diagnostic and prognostic biomarker in lung cancer patients.循环U2小核RNA片段作为肺癌患者的诊断和预后生物标志物
J Cancer Res Clin Oncol. 2016 Apr;142(4):795-805. doi: 10.1007/s00432-015-2095-y. Epub 2015 Dec 19.
6
Circulating miR-125b is a novel biomarker for screening non-small-cell lung cancer and predicts poor prognosis.循环 miR-125b 是一种新型非小细胞肺癌筛查生物标志物，可预测不良预后。
J Cancer Res Clin Oncol. 2012 Dec;138(12):2045-50. doi: 10.1007/s00432-012-1285-0. Epub 2012 Jul 18.
7
Prognostic and diagnostic usefulness of serum markers in lung cancer.血清标志物在肺癌中的预后和诊断价值
Eur J Cancer Clin Oncol. 1987 Jul;23(7):893-4. doi: 10.1016/0277-5379(87)90330-0.
8
The predictive value of ferroptosis marker SLC7A11 in the prognosis of advanced non-small cell lung cancer patients.铁死亡标志物SLC7A11对晚期非小细胞肺癌患者预后的预测价值
Clin Biochem. 2025 Aug;138:110961. doi: 10.1016/j.clinbiochem.2025.110961. Epub 2025 Jun 23.
9
MiR-519d targets HER3 and can be used as a potential serum biomarker for non-small cell lung cancer.miR-519d 靶向 HER3，可作为非小细胞肺癌的潜在血清生物标志物。
Aging (Albany NY). 2020 Mar 13;12(6):4866-4878. doi: 10.18632/aging.102908.
10
Evaluation of cumulative prognostic scores based on the systemic inflammatory response in patients with inoperable non-small-cell lung cancer.基于全身炎症反应的不可切除非小细胞肺癌患者累积预后评分评估
Br J Cancer. 2003 Sep 15;89(6):1028-30. doi: 10.1038/sj.bjc.6601242.
Zotero 插件